1-2 of 2
Ronit Gurion
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in lymphoma patients

Adi Zoref-Lorenz, Jun Murakami, Ronit Gurion, Swaminathan P. Iyer, Uri Abadi, Inbar Cohen, Guarav Goyal, Shehab Fareed Mohamed, Sarah Nikiforow, Abd El Haleem Natour, Shiri Weinstein, Joanne Yacobovich, Hae Lin Cho, Pia Raanani, Arnon Nagler, Nancy Berliner, Naval G. Daver, Gilad Itchaki, Shai Izraeli, Martin Ellis, Michael B. Jordan
Journal: Blood Advances
Blood Adv bloodadvances.2024014005.
https://doi.org/10.1182/bloodadvances.2024014005
Published: 2025
Includes: Supplemental data
Journal Articles

A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)

Clinical Trials & Observations
Tycel J. Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S. Lossos, Pier Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter Johnson
Journal: Blood Advances
Blood Adv (2024) 8 (4): 867–877.
https://doi.org/10.1182/bloodadvances.2023010648
Published: 2024
Includes: Supplemental data